A Phase 1 Dose Escalation Study of VX-993 in Healthy Participants
Clinical trial NCT05653323 · COMPLETED
Trial details
- NCT number
- NCT05653323
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-14
- Primary completion
- 2023-09-12
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.